New radioactive drug takes aim at hard-to-treat prostate cancer
NCT ID NCT06229366
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This early-phase trial tests an experimental drug called [Ac-225]-PSMA-62 in 142 men with a specific type of prostate cancer that shows up on a PSMA scan. The drug delivers a tiny dose of radiation directly to cancer cells. The main goals are to find the safest dose and to check for side effects and early signs that the drug is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC PROSTATE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BC Cancer Vancouver
Vancouver, V5Z4E6, Canada
-
Centre Hospitalier Universite de QUEBEC
Québec, G1J 1Z4, Canada
-
Hopital De Chicoutimi
Saguenay, G7H 5H6, Canada
-
Jewish General Hospital
Montreal, H3T 1E2, Canada
-
Juravinski
Hamilton, L8V 5C2, Canada
-
McGill University
Montreal, H4A 3J1, Canada
-
Princess Margaret Cancer Centre
Toronto, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.